On Wednesday, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on the nomination of Scott Gottlieb to be the next FDA Commissioner. Gottlieb, who served at the FDA during the Bush Administration, faced a range of questions related to his industry experience, drug pricing and competition, FDA workforce and the opioid crisis, among others. Gottlieb expressed his strong support for the 21st Century Cures Act passed by Congress last year. Many provisions in the law have FDA-related components, including a section on FDA regulation of health IT. The nomination hearing coincides with ongoing hearings in the HELP and Energy and Commerce Committees on the FDA User Fee Agreement Reauthorizations.